A landmark study from the US has shattered more than 40 years of conventional thinking about the causes of asymptomatic diverticulosis (AD).
Skindex-29 trumps other QoL measures
February 10, 2012 By Leave a Comment
The Skindex-29 quality of life measure displays better sensitivity to the clinical severity of psoriasis and more sensitivity to change than other commonly used quality of life (QoL) measures, new research shows.
Milk products found to alleviate gout
February 9, 2012 By Leave a Comment
Daily intake of enriched skimmed-milk powder can reduce the number of flares in patients with poorly controlled gout, a randomised trial has concluded.
Black tea linked to lower blood pressure
February 9, 2012 By Leave a Comment
Researchers have identified a link between regular black tea consumption and lower blood pressure (BP).
Study on delusional infestation prevalence
February 9, 2012 By Leave a Comment
Being female, disabled, having a psychiatric history and ‘doctor-hopping’ are some of the predominant characteristics of patients with delusional infestations, a new study finds.
Metformin may reduce pancreatic cancer risk in women — large study
February 8, 2012 By Leave a Comment
The diabetes drug metformin, previously linked with reduced pancreatic cancer risk, has been found by a new large-scale study to lower risk in women only.
Managing hypertension in diabetic patients
February 8, 2012 By Leave a Comment
Prof Eoin O’Brien looks at the benefits of aliskiren in the treatment of hypertension but says it should not be prescribed with ACE inhibitors or ARBs in diabetic patients.
GP management of shoulder issues
February 3, 2012 By Leave a Comment
Edel Comer and Victoria Percy look at the physiotherapy management of common shoulder-joint problems in the primary care setting.
FRAX the more clinically relevant measure
February 3, 2012 By Leave a Comment
In his latest Clinical Update, Gary Culliton examines recent developments in the field of osteoporosis, including diagnostic tools and issues related to glucocorticoids.
Increasing placebo response destroys evidence of benefit
February 3, 2012 By Leave a Comment
Despite older tricyclic antidepressants demonstrating a significantly greater efficacy over newer drugs, a major 30-year meta-analysis concludes the differences are largely a result of changes in trial designs, leading to greater placebo response and lower drug response.
Loading ...
